ConductScience.org, home

Paper7654491

Probenecid inhibits the renal clearance of frusemide and its acyl glucuronide.

Vree TB and 2 others. Br J Clin Pharmacol, 1995. Cited by 44 papers, by iCite.

Cite this record

ConductScience Library. Probenecid inhibits the renal clearance of frusemide and its acyl glucuronide. Papers, record 7654491. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7654491

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Probenecid inhibits the renal clearance of frusemide and its acyl glucuronide.
PubMed
Journal
Br J Clin Pharmacol
PubMed
Year
1995
PubMed
Publication types
Clinical Trial, Journal Article
PubMed
Citations, by iCite
44
iCite
Relative citation ratio, by iCite
1.69
iCite
Revised in PubMed
2018-11-13
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Vree TBT B
2van den Biggelaar-Martea MM
3Verwey-van Wissen CPC P

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
FurosemideMajor topic
GlucuronatesMajor topic
KidneyMajor topic
ProbenecidMajor topic
Adult
Aged
Aged, 80 and over
Binding Sites
Cross-Over Studies
Drug Interactions
Female
Humans
Male

Source PubMed

Download CSV of topics

References21

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11233253On the fate of furosemide in man.Eur J Clin Pharmacol1975https://conductscience.org/library/papers/1233253PubMed
28061834
Determination of furosemide with its acyl glucuronide in human plasma and urine by means of direct gradient high-performance liquid chromatographic analysis with fluorescence detection. Preliminary pharmacokinetics and effect of probenecid.
J Chromatogr B Biomed Appl1994https://conductscience.org/library/papers/8061834PubMed
3699479Effects of probenecid on furosemide response.Clin Pharmacol Ther1978https://conductscience.org/library/papers/699479PubMed
4458552Pharmacokinetics/pharmacodynamics of furosemide in man: a review.J Pharmacokinet Biopharm1979https://conductscience.org/library/papers/458552PubMed
5513505Pharmacodynamic analysis of the furosemide-probenecid interaction in man.Kidney Int1979https://conductscience.org/library/papers/513505PubMed
67381747Preliminary evaluation of furosemide-probenecid interaction in humans.J Pharm Sci1980https://conductscience.org/library/papers/7381747PubMed
76107232Absorption and disposition of furosemide in healthy volunteers, measured with a metabolite-specific assay.Drug Metab Dispos1980https://conductscience.org/library/papers/6107232PubMed
87452492Pharmacokinetic-dynamic analysis of the indomethacin-furosemide interaction in man.J Pharmacol Exp Ther1980https://conductscience.org/library/papers/7452492PubMed
96339277Furosemide assays and disposition in healthy volunteers and renal transplant patients.Fed Proc1983https://conductscience.org/library/papers/6339277PubMed
106350024Biotransformation of furosemide in kidney transplant patients.Eur J Clin Pharmacol1983https://conductscience.org/library/papers/6350024PubMed
116396057Properties of acyl glucuronides: implications for studies of the pharmacokinetics and metabolism of acidic drugs.Drug Metab Rev1984https://conductscience.org/library/papers/6396057PubMed
122867875Furosemide 1-O-acyl glucuronide. In vitro biosynthesis and pH-dependent isomerization to beta-glucuronidase-resistant forms.Drug Metab Dispos1985https://conductscience.org/library/papers/2867875PubMed
132654356Furosemide pharmacokinetics and pharmacodynamics in health and disease--an update.J Pharmacokinet Biopharm1989https://conductscience.org/library/papers/2654356PubMed
142185908Furosemide (frusemide). A pharmacokinetic/pharmacodynamic review (Part I).Clin Pharmacokinet1990https://conductscience.org/library/papers/2185908PubMed
151617949MW/Pharm, an integrated software package for drug dosage regimen calculation and therapeutic drug monitoring.Comput Biol Med1992https://conductscience.org/library/papers/1617949PubMed
161630876Direct measurement of probenecid and its glucuronide conjugate by means of high pressure liquid chromatography in plasma and urine of humans.Pharm Weekbl Sci1992https://conductscience.org/library/papers/1630876PubMed
171437517Capacity-limited renal glucuronidation of probenecid by humans. A pilot Vmax-finding study.Pharm Weekbl Sci1992https://conductscience.org/library/papers/1437517PubMed
188512758The pharmacokinetics of naproxen, its metabolite O-desmethylnaproxen, and their acyl glucuronides in humans. Effect of cimetidine.Br J Clin Pharmacol1993https://conductscience.org/library/papers/8512758PubMed
198220301Probenecid inhibits the renal clearance and renal glucuronidation of nalidixic acid. A pilot experiment.Pharm World Sci1993https://conductscience.org/library/papers/8220301PubMed
208156046Probenecid inhibits the glucuronidation of indomethacin and O-desmethylindomethacin in humans. A pilot experiment.Pharm World Sci1994https://conductscience.org/library/papers/8156046PubMed

See all 21 referencesDownload CSV of references

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 44 citations.

PMIDTitleJournalYearIn PapersSource
39994867Pyridoxic Acid as Endogenous Biomarker of Renal Organic Anion Transporter Activity: Population Variability and Mechanistic Modeling to Predict Drug-Drug Interactions.CPT Pharmacometrics Syst Pharmacol2025https://conductscience.org/library/papers/39994867PubMed
37896187The Impact of Inflammation on the In Vivo Activity of the Renal Transporters OAT1/3 in Pregnant Women Diagnosed with Acute Pyelonephritis.Pharmaceutics2023https://conductscience.org/library/papers/37896187PubMed
37866801Effect of probenecid on blood levels and renal elimination of furosemide and endogenous compounds in rats: Discovery of putative organic anion transporter biomarkers.Biochem Pharmacol2023https://conductscience.org/library/papers/37866801PubMed
36769175Kidney Drug Transporters in Pharmacotherapy.Int J Mol Sci2023https://conductscience.org/library/papers/36769175PubMed
33403255Contribution of Uptake and Efflux Transporters to Oral Pharmacokinetics of Furosemide.ACS Omega2020https://conductscience.org/library/papers/33403255PubMed
33237382Physiologically Based Pharmacokinetic Models of Probenecid and Furosemide to Predict Transporter Mediated Drug-Drug Interactions.Pharm Res2020https://conductscience.org/library/papers/33237382PubMed
33062845Evaluation of Renal Anionic Secretion Following Living-donor and Deceased-donor Renal Transplantation: A Clinical Pharmacokinetic Study of Cefoxitin Microdosing.Transplant Direct2020https://conductscience.org/library/papers/33062845PubMed
32504272Validation of a Drug Transporter Probe Cocktail Using the Prototypical Inhibitors Rifampin, Probenecid, Verapamil, and Cimetidine.Clin Pharmacokinet2020https://conductscience.org/library/papers/32504272PubMed
31675437Inhibitory Effects of Probenecid on Pharmacokinetics of Tenofovir Disoproxil Fumarate and Emtricitabine for On-Demand HIV Preexposure Prophylaxis.Clin Pharmacol Ther2020https://conductscience.org/library/papers/31675437PubMed
29627897Drug-drug interaction of cefiderocol, a siderophore cephalosporin, via human drug transporters.Eur J Clin Pharmacol2018https://conductscience.org/library/papers/29627897PubMed
28749581Prediction of Transporter-Mediated Drug-Drug Interactions for Baricitinib.Clin Transl Sci2017https://conductscience.org/library/papers/28749581PubMed
27709005Renal drug transporters and their significance in drug-drug interactions.Acta Pharm Sin B2016https://conductscience.org/library/papers/27709005PubMed
25972096Transporter-Mediated Disposition of Opioids: Implications for Clinical Drug Interactions.Pharm Res2015https://conductscience.org/library/papers/25972096PubMed
23649425Reduced renal clearance of cefotaxime in asians with a low-frequency polymorphism of OAT3 (SLC22A8).J Pharm Sci2013https://conductscience.org/library/papers/23649425PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7654491

GET https://conductscience.org/api/papers/v1/7654491/references?page=2